foxo4 dri peptide senolytic 2023 study

foxo4 dri peptide senolytic 2023 study foxo4-dri mouse 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI The disordered p53 transactivation domain

Name: foxo4 dri peptide senolytic 2023 study foxo4-dri mouse 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI The disordered p53 transactivation domain
Brand: equiscorp.hu
SKU: 63068796446
Price: 29.54 USD
Availability: InStock
Rating: 4.690300000000001 (23 reviews)

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI Greece PharmaGrade.Store Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC

SKU: 63068796446 · From equiscorp.hu

4.7

USD29.54 USD75.54

Pay in 4 interest-free payments of $7.38 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

Nishimura, S

The regulatory landscape of mtDNA 6mA is complex and likely influenced by factors such as the DNA N6-adenine methyltransferase DAMT1 and demethylases such as N6-methyladenine demethylase 1 (NMAD1) and AlkB homolog 1, histone H2A dioxygenase (ALKBH1), although their role in mitochondria requires further clarification